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In this sense, we can see that the study of 
epidemics as mosaics of knowledge and power 
emphasizes the social, cultural and political char-
acteristics of configurations built of elements al-
ready existing in the social world, more than 
characteristics resulting from biological or medical 
factors. Epidemics are a sound board reflecting 
the variations of the social world, reverberations 
with a melody to which an attentive researcher is 
always willing to listen so as to better comprehend 
the totality of a problem from different points of 
view. this includes the tensions and contradic-
tions of local experiences seen in the medical and 
scientific field, in the layperson, in public health 
policies and in the ways in which those policies 
are received and interpreted by individuals in their 
everyday lives. 
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dr. Juan Pablo Zabala’s work (1) shows a pro-
found knowledge of the difficulties arising in the 
fight against the principal endemic parasitic disease 
in argentina. Moreover, it puts into evidence the 
different causalities, actors and detractors that affect 
the success of efforts made towards this task, and 
provides a very interesting historical outline of what 
has happened in argentina.
I would like to highlight Zabala’s statement that 
“Chagas disease has neither been so neglected as to 
disappear from the political agenda nor so present 
as to put a permanent end to its reproduction cycle” 
(1 p.10). this concept clearly explains the reason 
why good results have not yet been obtained: dis-
continuity in the tasks carried out.
the author mentions two main elements 
when discussing the actors responsible for this 
“failure”: a) scientific and technocratic aspects, 
and b) political and commercialist aspects. 
Within this first group the author mentions 
the nonexistence of a vaccine. However, it should 
be recalled that to date vaccines have been de-
veloped for viruses, bacteria and toxins, but thus 
far not for parasites, due among other reasons 
to the great biological complexity of protozoa. 
another example of this has been the impossi-
bility of developing a vaccine for a protozoan with 
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a much greater impact on health, Plasmodium, 
which is responsible for malaria. 
Regarding the political and commercialist as-
pects, since the 1950s, a decade which marks the 
beginning of actions against this endemic disease, 
the interest of governments has been disparate. 
Another difficulty arises from the federalism of 
the country: each province decides, organizes 
and enforces its own health measures; and not all 
provinces have shown equal interest in carrying 
out actions to this end. In fact, in some provinces, 
many of the gains achieved have resulted from the 
strong interest of certain heads of provincial pro-
grams who diligently and tirelessly work to assure 
that necessary tasks are carried out. 
the author further states that “Chagas is a 
complex entity conditioned by the biological pro-
cesses involved as well as the professional, eco-
nomic, political, cultural and institutional interests 
at stake” (1 p.10). this statement addresses a factor 
common to most diseases. Nevertheless, it is worth 
mentioning that many countries have managed to 
interrupt domiciliary vectoral transmission. this 
means that if there is sufficient interest and com-
mitment, achievements are possible, even given 
the gaps existing in our current knowledge. 
Within the paradoxes mentioned by the author, 
I would like to reflect upon some of the biomedical 
aspects regarding the infected-sick dichotomy. It is 
common to assert that we should not scare a person 
who has reactive serology but normal electrocardio-
grams (eCG) and chest X-rays by labeling him or her 
as “sick.” but this implies making a serious mistake: 
all individuals who develop severe morbidity and 
even die because of this infection went through 
an asymptomatic stage at some point. Something 
similar occurs in patients with hypertension, as they 
may have high blood pressure without exhibiting 
any other symptoms, but they can later develop 
severe diseases. do we not call a person with as-
ymptomatic hypertension “sick”? Moreover, if 
cardiac diagnostic procedures of greater sensitivity 
were carried out in Chagas disease patients, cardiac 
alterations could be detected in individuals with a 
normal eCG. this is what brought about the current 
redefinition of patients in the chronic stage: a) those 
with demonstrated pathology or b) those without 
demonstrated pathology (2). 
also excellent is the description of the vicis-
situdes the disease has undergone since Carlos 
Chagas attributed goiterism to Trypanosoma cruzi. 
this demonstrates that the brilliant researcher who 
discovered the disease is also a human being ca-
pable of making erroneous interpretations.
among the actors responsible for carrying 
out actions related to Chagas, it is important to 
mention physicians, who are generally not in-
terested in taking on this disease. this resistance 
could have many possible explanations: a) they 
are unaware of Chagas disease and its natural 
history in infected individuals; b) they are unaware 
of the benefits of initiating antiparasitic treatment; 
c) they fear the side effects that could be produced 
by the only two drugs available since the 1970s; 
d) they are not under pressure from the pharma-
ceutical industry. these situations lead to a lack of 
interest in treating Chagas disease patients, aside 
from the fact that such treatment does not provide 
them any economic benefits. All of this could 
be solved, in part, with sustained education and 
training activities. 
With reference to a paragraph in Zabala’s ar-
ticle dealing with “neglected diseases,” they are 
a common occurrence not only in Latin america, 
africa and asia, but also in the United States, 
where patients with this parasitosis do not receive 
proper medical care.
It is also highlighted that there are many types 
of difficulties in adequately fighting the vector in 
geographical areas like the Greater Chaco, due to 
its climatic, housing and phytogeographical char-
acteristics, among others. Nevertheless, it is worth 
mentioning that the interruption of domiciliary 
vectoral transmission has just been certified in 
four departments of the province of Santiago del 
estero, in the very heart of the Greater Chaco (3). 
this clearly shows that when there is political de-
cision, action is taken in spite of the adversities. 
Also appropriate are the author’s reflections 
on the importance of research in the progress of 
this fight, which has to a greater extent contributed 
to the improvement of diagnoses and some ento-
mological aspects (resistance to insecticides, con-
centrated use of insecticides). 
With regard to medications we can affirm that 
although no new drugs are available yet, the two tra-
ditional drugs can be used: benznidazol (made by 
an argentine company) and nifurtimox (again being 
produced by the laboratory). Furthermore, clinical 
trials are being conducted on humans to test drugs 
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for the treatment of fungi that have also proven ef-
fective for Trypanosoma cruzi in animal models. 
Lastly, I would like to stress the role of the 
international NGO drugs for Neglected diseases 
Initiative (dNdi), which is tirelessly struggling to 
secure greater access to drugs worldwide, and 
doctors Without borders, with its vast experience 
in diagnosis and treatment in different countries of 
the americas. Other argentine foundations with 
active participation in Chagas disease control are 
Mundo Sano and bunge y born. I would also like 
to point out that Chagas disease has undergone 
a great epidemiological change: it has been ur-
banized owing to migrations from endemic areas. 
a large number of infected children and adults 
live in big and small cities in different parts of the 
world. In argentina, medical care must be pro-
moted in the three existing health care systems: 
the public system, the employment-based in-
surance system and the private system. In all three 
patients with Chagas disease can be found. 
albeit with ups and downs, both vectoral and 
non-vectoral actions are progressing in argentina 
and the figures are encouraging. Much has been 
done, but there is still much more to do.
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Juan Pablo Zabala’s article (1) puts into evi-
dence the paradoxes of Chagas disease since its 
discovery, based on a criterion of the “visibility 
and invisibility of the disease.” Unfortunately, the 
disease generally becomes visible when the elec-
tions of municipal officers, governors or presidents 
draw near. the promises made to this population 
living in conditions of poverty are decent housing, 
periodic fumigation, better nutrition, electricity and 
running water. However, after the elections these 
promises are not fulfilled. The people who do have 
the disease in mind are field researchers and those 
who devote themselves to the everyday care and 
follow-up of these patients in big cities. 
the invisibility is created by society, which is 
generally unaware of the existence of people with 
this disease because they believe that only the poor 
are affected, never imagining that the disease can 
be contracted through blood transfusion, vertical 
(mother to child) transmission, or addiction to in-
travenous drugs by endogenous reinfection due 
to sharing a needle with a person with reactive se-
rology (2). this disease is hidden by those infected 
to avoid employment discrimination, by health 
